Menin drugs for Acute Lymphoblastic Leukemia

2 tracked Menin drugs in the Acute Lymphoblastic Leukemia race. The class explanation lives on the Menin page; the full indication pipeline across every mechanism is on the Acute Lymphoblastic Leukemia page.

1 approved / phase 41 Phase 1/2

Head-to-head evidence: Revumenib vs Ziftomenib

The roster

← all Menin drugs